Using Twin Data to Identify Alternative Drug-Abuse Phenotypes, Ming T. Tsuang, M.D., Department of Psychiatry, Harvard Medical School/Mass Mental Health Ctr, 74 Fenwood Road, Boston, MA 02115; Michael Lyons, Ph.D., Stephen V. Faraone, Ph.D., William Kremen, Ph.D., Stephen Glatt, Ph.D.

Common and Specific Genetic Factors in the Development of Substance Dependence.
Laura J. Bierut, M.D., Department of Psychiatry, Washington University, 660 South Euclid, Box 8134, St. Louis, MO 63110; Alison Goate, D.Phil., John Rice, Ph.D., Anthony Hinrichs, Ph.D., Tatiana Foroud, Ph.D., Howard Edenberg, Ph.D., Raymond R. Crowe, M.D.

Addiction Molecular Genetics: Remarkably Converging Results
George Uhl, M.D., Department of Molecular Neurobiology, National Institute on Drug Abuse, IRP, 5500 Nathan Shock Drive, Baltimore, MD 21224

Using the Systems Biology of Motivation For Genetic Studies in Psychiatry
Gregory P. Gasic, Ph.D., Department of Radiology, Harvard Medical School, Mass General Hospital, Building 149-2301, 13th Street, Boston, MA 02129-2060; Hans C. Breiter, M.D.

Genetic and Environmental Factors Modulate Cocaine Abuse in Monkey Models
Michael Nader, Ph.D., Department of Physiol/Pharm, Wake Forest University, Medical Center Boulevard, Winston Salem, NC 27157

NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version _ The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Wednesday, November 3, 2004.